Tie1 deficiency induces endothelial-mesenchymal transition

EMBO Reports

Volumn 13, Issue 5, 2012, Pages 431-439

  Garcia, Julie ^a,b   Sandi, Maria José ^a,b   Cordelier, Pierre ^a   Binétruy, Bernard ^a,b   Pouysségur, Jacques ^c   Iovanna, Juan Lucio ^a,b   Tournaire, Roselyne ^a,b  

^a INSERM   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c CENTRE DE BIOCHIMIE   (France)

Author keywords

angiogenesis; endothelial mesenchymal transition; pancreatic cancer; Slug; Tie1

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 7; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE TIE1; PROTEIN TYROSINE KINASE TIE2; TRANSCRIPTION FACTOR SLUG; UNCLASSIFIED DRUG;

ARTICLE; CANCER ASSOCIATED FIBROBLAST; CARCINOGENESIS; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIAL MESENCHYMAL TRANSITION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; FIBROBLAST; GENE ACTIVATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PANCREAS TUMOR; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN TYROSINE KINASE TIE1 DEFICIENCY; SIGNAL TRANSDUCTION; STROMA;

CELL ADHESION; CELL MOVEMENT; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; ENDOTHELIUM; HUMANS; IMMUNOBLOTTING; MALE; MESODERM; MICROSCOPY, CONFOCAL; NEOVASCULARIZATION, PATHOLOGIC; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, TIE-1; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84863406596     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/embor.2012.29     Document Type: Article

References (23)

1. Potenta S, Zeisberg E, Kalluri R (2008) The role of endothelial- tomesenchymal transition in cancer progression. Br J Cancer 99: 1375-1379
2. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelialmesenchymal transitions in development and disease. Cell 139: 871-890
3. Zeisberg EM et al (2007) Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 138: 952-961 (Pubitemid 47222040)
4. Zeisberg EM, Potenta S, Xie L, Zeisberg M, Kalluri R (2007) Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res 6721: 10123-10128 (Pubitemid 350070783)
5. Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6: 392-401
6. Augustin HG, Koh GY, Thurston G, Alitalo K (2009) Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 10: 165-177
7. Huang H, Bhat A, Woodnutt G, Lappe R (2010) Targeting the ANGPT-TIE2 pathway in malignancy. Nat Rev Cancer 10: 575-585
8. Tournaire R, Simon MP, le Noble F, Eichmann A, England P, Pouysségur J (2004) A short synthetic peptide inhibits signal transduction, migration and angiogenesis mediated by Tie2 receptor. EMBO Rep 5: 262-267 (Pubitemid 38500105)
9. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y (1995) Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376: 70-74
10. Saharinen P, Kerkelä K, Ekman N, Marron M, Brindle N, Lee GM, Augustin H, Koh GY, Alitalo K (2005) Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2. J Cell Biol 169: 239-243 (Pubitemid 40656562)
11. Crosby CV, Fleming PA, Argraves WS, Corada M, Zanetta L, Dejana E, Drake CJ (2005) VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly. Blood 105: 2771-2776 (Pubitemid 40446268)
12. Ai KX, Lu LY, Huang XY, Chen W, Zhang HZ (2008) Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancer. World J Gastroenterol 14: 1931-1935 (Pubitemid 351523827)
13. Grotendorst GR, Seppä HE, Kleinman HK, Martin GR (1981) Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. Proc Natl Acad Sci USA 78: 3669-3672 (Pubitemid 11062414)
14. Regan CP, Li W, Boucher DM, Spatz S, Su MS, Kuida K (2002) Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects. Proc Natl Acad Sci USA 99: 9248-9253 (Pubitemid 34764599)
15. Nishimoto S, Nishida E (2006) MAPK signalling: ERK5 versus ERK1/2. EMBO Rep 7: 782-786 (Pubitemid 44275395)
16. Arnoux V, Nassour M, L'Helgoualc'h A, Hipskind RA, Savagner P (2008) Erk5 controls Slug expression and keratinocyte activation during wound healing. Mol Biol Cell 19: 4738-4749
17. Morita T, Mayanagi T, Sobue K (2007) Dual roles of myocardin-related transcription factors in epithelial mesenchymal transition via Slug induction and actin remodeling. J Cell Biol 179: 1027-1042 (Pubitemid 350223496)
18. Farrow B, Albo D, Berger DH (2008) The role of the tumor microenvironment in the progression of pancreatic cancer. J Surg Res 149: 319-328
19. Erkan M, Reiser-Erkan C, Michalski CW, Kleeff J (2010) Tumor microenvironment and progression of pancreatic cancer. Exp Oncol 32: 128-131
20. Li K et al (2010) A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivo. Blood 115: 133-139
21. Marron MB, Singh H, Tahir TA, Kavumkal J, Kim HZ, Koh GY, Brindle NP (2007) Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor-tyrosine kinase Tie2. J Biol Chem 282: 30509-30517 (Pubitemid 350035225)
22. Erkan M, Michalski CW, Rieder S, Reiser-Erkan C, Abiatari I, Kolb A, Giese NA, Esposito I, Friess H, Kleeff J (2008) The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. Clin Gastroenterol Hepatol 6: 1155-1161
23. Deissler H, Deissler H, Lang GK, Lang GE (2006) TGFb induces transdifferentiation of iBREC to aSMA-expressing cells. Int J Mol Med 18: 577-582